Holen Sie sich die Stockscreener-App
12.46
3.83%
0.46
Handel nachbörslich:
12.46
Schlusskurs vom Vortag:
$12.00
Offen:
$11.85
24-Stunden-Volumen:
1.09M
Relative Volume:
4.11
Marktkapitalisierung:
$462.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.78M
KGV:
-4.7019
EPS:
-2.65
Netto-Cashflow:
$-53.91M
1W Leistung:
-0.48%
1M Leistung:
-2.50%
6M Leistung:
-19.97%
1J Leistung:
-13.59%
1-Tages-Spanne:
$11.62
$12.59
1-Wochen-Bereich:
$11.62
$13.02
52-Wochen-Spanne:
$11.51
$22.19
Celcuity Inc Stock (CELC) Company Profile
Firmenname
Celcuity Inc
Sektor
Branche
Telefon
763-392-0767
Adresse
16305 36TH AVENUE N, MINNEAPOLIS, MN
Vergleichen Sie CELC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
12.46 | 462.63M | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-22 | Eingeleitet | Stifel | Buy |
| 2023-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-07 | Eingeleitet | Jefferies | Buy |
| 2021-07-29 | Eingeleitet | Cowen | Outperform |
| 2021-07-27 | Eingeleitet | Needham | Buy |
| 2021-01-28 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-11 | Fortgesetzt | Craig Hallum | Buy |
| 2018-11-20 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Celcuity Inc Aktie (CELC) Neueste Nachrichten
Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts - MarketBeat
Wellington Management Group LLP Makes New Investment in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity (CELC) Charges Forward with Promising Potential Cancer Treatments - TipRanks
Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat
Charles Schwab Investment Management Inc. Acquires 153,712 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
BNP Paribas Financial Markets Raises Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
BNP Paribas Financial Markets Has $673,000 Stake in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity reports survival data for breast cancer drug - Investing.com
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium - The Manila Times
Celcuity Presents Overall Survival Data from Phase 1b Study - GlobeNewswire
Verition Fund Management LLC Reduces Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Braidwell LP Buys 367,663 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Celcuity’s (CELC) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
Celcuity’s (CELC) “Buy” Rating Reiterated at HC Wainwright - Defense World
Celcuity (NASDAQ:CELC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Celcuity stock hits 52-week low at $12.14 amid market shifts - Investing.com
500: Something went wrong - Investing.com India
Earnings call: Celcuity reports Q3 2024 financials and clinical trial updates - Investing.com
Celcuity's (CELC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Q3 2024 Earnings Call Transcript - Insider Monkey
RA Capital Management, L.P. Acquires New Stake in Celcuity Inc - GuruFocus.com
Celcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial Challenges By GuruFocus - Investing.com Canada
COMMODORE CAPITAL LP's Strategic Acquisition of Celcuity Inc Sha - GuruFocus.com
Celcuity Inc. Reports Q3 Progress and Financials - TipRanks
Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update - The Manila Times
Celcuity CEO to Present at Stifel and Jefferies Healthcare Conferences This Month | CELC Stock News - StockTitan
Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences - GlobeNewswire
Long Term Trading Analysis for (CELC) - Stock Traders Daily
Celcuity (CELC) Scheduled to Post Earnings on Thursday - MarketBeat
Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call - GlobeNewswire
Celcuity (CELC) to Report Q3 2024 Earnings: Oncology Pipeline Update Coming | CELC Stock News - StockTitan
Celcuity: Breast Cancer Drug Developer With Upcoming Catalysts (NASDAQ:CELC) - Seeking Alpha
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Analysts Set Celcuity Inc. (NASDAQ:CELC) PT at $29.17 - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Short Interest Up 9.3% in October - MarketBeat
Asml Holdings NY Reg ADR (ASML-Q) QuotePress Release - The Globe and Mail
Celcuity director Buller sells $5,687 in stock - Investing.com India
Celcuity director Buller sells $5,687 in stock By Investing.com - Investing.com Australia
Objective long/short (CELC) Report - Stock Traders Daily
Short Interest in Celcuity Inc. (NASDAQ:CELC) Rises By 26.7% - MarketBeat
Celcuity Inc. expands share authorization to 95 million By Investing.com - Investing.com Australia
Celcuity Inc. expands share authorization to 95 million - Investing.com India
Celcuity (NASDAQ:CELC) Files 8-K Disclosing Change in Directors or Principal Officers - MarketBeat
Celcuity (NASDAQ:CELC) Stock Price Down 4.5%Here's What Happened - MarketBeat
Morgan Stanley's Strategic Reduction in Celcuity Inc Holdings - GuruFocus.com
Finanzdaten der Celcuity Inc-Aktie (CELC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Celcuity Inc-Aktie (CELC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Buller Richard E | Director |
Oct 23 '24 |
Sale |
16.25 |
350 |
5,688 |
6,681 |
| Buller Richard E | Director |
Aug 23 '24 |
Sale |
16.95 |
350 |
5,932 |
7,031 |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):